Work

Intravitreous Plasma Kallikrein (PK) Inhibition for Diabetic Macular Edema: A Phase 1 Study of the Novel PK Inhibitor KVD001

Year: 2016

Type: article

Source: Investigative Ophthalmology & Visual Science

Authors: Jennifer K. Sun, Raj K. Maturi, David S. Boyer, John A. Wells, Víctor H. González, Robert Tansley, Helen Hernandez, Lloyd Paul Aiello

Institutions: Joslin Diabetes Center, Harvard University, Midwest Eye Institute, Retina Vitreous Associates Medical Group, Palmetto Retina Center, Valley Retina Institute

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,850

OpenAlex ID: W2578688062

FWCI:

Cites:

Cited by: 1

Related to: 10